[Federal Register Volume 83, Number 223 (Monday, November 19, 2018)]
[Notices]
[Pages 58267-58268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25116]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory
Board (DTAB) will convene via in person and web conference on December
4, 2018, from 9:00 a.m. EST to 3:30 p.m. EST and December 5, 2018, from
9:00 a.m. EST to 4:00 p.m.
The Board will meet in open-session in-person on December 4, 2018,
from 9:00 a.m. EST to 3:30 p.m. EST to discuss the proposed Mandatory
Guidelines for Federal Workplace Drug Testing Programs (urine
specimens) with updates from the Department of Transportation, Nuclear
Regulatory Commission, and the Department of Defense. There will be
additional presentations from the Division of Workplace Programs' staff
on urine, oral fluid, hair Mandatory Guidelines and future direction,
updates on electronic chain of custody and standard variables, and
emerging issues surrounding marijuana legalization. The board will meet
in closed-session in-person on
[[Page 58268]]
December 5, 2018, from 9:00 a.m. EST to 4:00 p.m. EST to discuss
confidential issues surrounding the proposed Mandatory Guidelines for
Federal Workplace Drug Testing Programs (urine specimens, oral fluid,
hair), invalids, studies from Johns Hopkins Behavioral Pharmacology
Research Unit, impact of cannabis laws on drug testing and future
direction, potential recommendations to the Assistant Secretary for
Mental Health and Substance Use regarding additional drugs that may be
tested for in the future, and lastly, program financials. Therefore,
the December 5, 2018, meeting is closed to the public, as determined by
the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in
accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2,
Section 10(d).
Meeting registration information can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call
information will be sent after completing registration. Meeting
information and a roster of DTAB members may be obtained by accessing
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal
Officer, CAPT Sean J. Belouin, USPHS.
Committee Name: Substance Abuse and Mental Health Services
Administration, Center for Substance Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: December 4, 2018, from 9:00 a.m. to 3:30 p.m.
EST: Open; December 5, 2018, from 9:00 a.m. to 4:00 p.m. EST:
Closed.
Place: Hilton Washington DC/Rockville Hotel & Executive Meeting
Center, 1750 Rockville Pike, Rockville, MD 20852.
Contact: CAPT Sean J. Belouin, USPHS, Senior Pharmacology and
Regulatory Policy Advisor, Division of Workplace Programs, 5600
Fishers Lane, Room 16N06D, Rockville, Maryland 20857, Telephone:
(240) 276-2600, Email: [email protected].
Charles LoDico,
Chemist.
[FR Doc. 2018-25116 Filed 11-16-18; 8:45 am]
BILLING CODE 4162-20-P